Side Effects of Sputnik V, Sinopharm, and AstraZeneca COVID-19 Vaccines among Healthcare Workers.
| Autor: | Ghasemi, Masoomeh, Khosravi, Sajad, Malekyan, Leila, Faridi, Amin, Gheshlaghi, Leili Abedi, Sobhanipoor, Mohammad Hossein, Isaei, Elham |
|---|---|
| Předmět: |
CROSS-sectional method
RISK assessment VACCINATION complications FISHER exact test FATIGUE (Physiology) HEADACHE SHIVERING COVID-19 vaccines DESCRIPTIVE statistics CHI-squared test AGE distribution DISEASE prevalence FEVER ORAL diseases INJECTIONS JOINT pain COMPARATIVE studies DATA analysis software DRUG eruptions COVID-19 IMMUNITY NAUSEA |
| Zdroj: | Journal of Occupational Health & Epidemiology; Spring2024, Vol. 13 Issue 2, p70-75, 6p |
| Abstrakt: | Background: Vaccines during the pandemic COVID-19 were the best solution to overcome the pandemic. The aim of this study was to evaluate and compare Sputnik V, Sinopharm, and AstraZeneca vaccins' side effects. Material and Methods: A cross-sectional study was designed among healthcare workers in a teaching hospital. The checklist was prepared for collecting data of demographic variables, respondents' medical history, and vaccines side effects. Results: More than half of participants received Sinopharm, while the development of COVID-19 following AstraZeneca was significantly among smaller proportion of respondents than other vaccines (P< 0.0001). There was no significant difference between age group and general side effects. The prevalence of serious side effects was higher in healthcare workers younger than 40 years old (P< 0.0001). The emergence of oral side effects was higher in participants who received two doses of vaccines in comparison to individuals who received one dose (P< 0.0001). Conclusion: The prevalence of serious side effects was higher in sputnik V in comparison to the other vaccines. The vaccines serious side effects were linked to the age of vaccinated people and immune system responses. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|